American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines

Journal of Clinical Oncology

Volumn 17, Issue 3, 1999, Pages 1080-1082

  Smith, Thomas J ^a   Davidson, Nancy E ^a   Schapira, David V ^a   Grunfeld, Eva ^a   Muss, Hyman B ^a   Vogel III, Victor G ^a   Somerfield, Mark R ^a  

^a American Society of Clinical Oncology   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

BLOOD CELL COUNT; BONE SCINTISCANNING; BREAST CANCER; BREAST EXAMINATION; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; ECHOGRAPHY; HUMAN; MAMMOGRAPHY; PERIODIC MEDICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 0033011071     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.3.1080     Document Type: Review

References (5)

1. American Society of Clinical Oncology: Recommended breast cancer surveillance guidelines. J Clin Oncol 15:2149-2156, 1997
2. Grunfeld E. Mant D, Yudkin P, et al: Routine follow-up of breast cancer in primary care: Randomized trial. BMJ 313:665-669, 1996
3. American Society of Clinical Oncology: 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. J Clin Oncol 16:793-795, 1998
4. Chan DW, Beveridge RA, Hyman M, et al: Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease. J Clin Oncol 15:2322-2328, 1997
5. American Society of Clinical Oncology: Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 14:671-679, 1996